- £16.97m
- £15.85m
- £6.53m
Brief: Ixico Signs Commercial Agreement With Petnet Solutions
Commercial agreement with PETNET Solutions Inc
Brief: Ixico PLC Signs Contract For Phase 2 Huntington's Disease Trial
Contract Win
Share Option Award & PDMR Dealings
Brief: IXICO FY Revenue GBP 5.8 Mln
Financial Results for year ended 30 September 2024
Notice of Results and Investor Presentation
Share Option Awards & PDMR Dealing
Ixico Plc Canaccord Genuitygrp: Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Holding(s) in Company
Director/PDMR Shareholdings
Result of GM, Issue of Equity & TVR
Holding(s) in Company
Director/PDMR Shareholding
Result of Retail Offer
Exercise of Options & Director/PDMR Purchase